Clinical Trials for Ardelyx

Explore 6 clinical trials worldwide

Showing 1-6 of 6 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Ardelyx

Clinical Trials (6)

NCT06810167
Assessing Tenapanor as a Treatment of CF-related Constipation.
PHASE3Recruiting
25 participants
Started: Jun 1, 2025 · Completed: Jun 30, 2027
2 conditions2 sponsors1 location
NCT06460038
Tenapanor in Synucleinopathy-Related Constipation
PHASE2Recruiting
30 participants
Started: Jan 1, 2025 · Completed: Mar 31, 2027
2 conditions2 sponsors1 location
NCT06553547
4-Week, Multi-center Dose-Ranging Study for the IBS-C in Pts. 6 to <12 Yrs
PHASE2Recruiting
72 participants
Started: Jul 24, 2024 · Completed: Jun 30, 2026
1 condition1 sponsor2 locations
NCT05995899
Effect of Tenapanor on the Metagenomics and Metabolomics of Patients With Irritable Bowel Syndrome With Constipation
PHASE4Active, not recruiting
30 participants
Started: Feb 6, 2024 · Completed: Oct 31, 2025
2 conditions2 sponsors1 location
NCT05905926
Safety Study of Tenapanor for the Treatment of Pediatric Patients (6 to Less Than 18 Years Old) With IBS-C
PHASE3Enrolling by invitation
150 participants
Started: Feb 17, 2023 · Completed: Oct 31, 2031
1 condition1 sponsor20 locations
NCT05643534
Study to Assess Safety and Efficacy of Tenapanor for Treatment of IBS-C in Pediatric Patients 12 to Less Than 18 Years
PHASE3Recruiting
180 participants
Started: Nov 15, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor33 locations